DCVC
About DCVC
DCVC is a leading deep tech venture capital firm that backs entrepreneurs solving high-stakes, hard problems across a range of industries. With a focus on deep technology, the firm supports companies in areas such as climate, computational biology, cybersecurity, industrial transformation, space, and TechBio/TechMed, primarily in the United States. DCVC emphasizes scientific expertise and long-term value creation, partnering with portfolio companies from early stages to support groundbreaking research and commercialization. The firm maintains a presence in California, including Palo Alto and San Francisco, and highlights its data-driven approach to identifying transformative technologies.
Recent News
Latus Bio Secures $97 Million Series A to Scale Gene‑Therapy Access
Quantum Motion Secures $160M Series C to Scale Silicon Spin QPUs
Unconventional AI Lands $475M in Seed Funding
Syneron Raises $150m for Macrocyclics, and Other Financings
Fortem Receives New Lockheed Backing, Reliable Robotics Completes Series B Raise
Unconventional AI Confirms Its Massive $475M Seed Round
NY Tech Week – SOSV Presents: The Agentic VC
US Energy Storage Startup Moves In On The Residential Market With Another $232 Million
Fusion Doesn’t Have a Normal Startup Timeline, and Investors Are Fine with That
Latus Bio Raises $97M to Expand Gene Therapy Pipeline
The Gates Foundation Is Funding A Startup’s Plan To Fight Malnutrition With Bacteria
Quantum Motion Secures $160 Million Series C to Scale Silicon Spin Qubits
Proxima Raises $80M in Seed Funding
Latus Bio Secures $97 Million Series A to Scale Gene‑Therapy Manufacturing
Curative Lands $150M Series B Round
Kanvas Biosciences Receives New Funding to Develop First-In-Category Microbiome Therapeutic for Improving Maternal, Newborn and Child Health
The Talent Profile Europe's Top AI Scaleups Are Chasing
Sector Snapshot: Insurtech Funding Is Way Down, But AI Is Still Driving Some Big Deals
Funding Roundup: Kanvas Biosciences, LTZ Therapeutics Draw Investor Interest for Next-Generation Cancer Immunotherapies
SOSV Deep Tech Live – The Atomic Architect: Rick Gottscho on Plasma’s Role in Semiconductor Fabrication & Physical AI Infrastructure
UK Tech Funding Roundup: This Week’s Deals From Quantum Motion to Lunar
Recent Deals
Iceberg Quantum Raises $6M Seed Round Led by LocalGlobe
Nilo Therapeutics Raises $101M Series A Led by The Column Group, DCVC Bio and Lux Capital
Curative Health Insurance Raises $150M Series B Funding
AgZen Secures $10M Series B Funding
Seneca Raises $60M Led by Caffeinated Capital and Convective Capital
Nilo Therapeutics Raises $101M Series A to Advance Neural-Circuit Therapies
Unconventional AI Secures $475M Seed Round Led by Andreessen Horowitz and Lightspeed
Seneca Launches Publicly with $60M Funding Led by Caffeinated Capital and Convective Capital
Kanvas Biosciences Secures $48M Series A Funding Co-Led by DCVC and Lions Capital
Unconventional AI Secures $475M Seed Round at $4.5B Valuation